AEROSURF

AEROSURF. AEROSURF® (lucinactant for inhalation), a combination drug/device product that utilizes lyophilized synthetic KL4 Surfactant with the Company's proprietary aerosol delivery system, based primarily on the Company's capillary aerosol generator technology, to produce aerosolized KL4 Surfactant for non-invasive aerosolized delivery.

AEROSURF. Discovery Labs' investigational combination drug/device product that combines Discovery Labs' proprietary technologies: lyophilized synthetic KL4 surfactant for inhalation and its capillary aerosol generator (CAG). For the purposes of this Agreement, "AEROSURF" means AEROSURF for the treatment of respiratory distress syndrome (RDS) in premature infants.